- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04031950
Evaluación clínica de una tecnología de diagnóstico del sueño pediátrico
The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.
The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography or cardio-respiratory polygraphy, assess acceptance of the novel system in the home environment, assess validity in patients on ventilation, and on a cohort with BMI SDS of 3 or more.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.
The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography or cardio-respiratory polygraphy, assess acceptance of the novel system in the home environment, assess validity in patients on ventilation, and on a cohort with BMI SDS of 3 or more.
Patients who are referred to the clinic for the first and second group will spend one night's sleep in the clinic for group 1 and group 2. They will wear a polysomnography or cardio-respiratory polygraphy system (current goldstandard) and the novel device. At the end of the trial, we will compare the diagnosis results from both systems.
Patients who are referred for home diagnosis of sleep apnoea or overnight oximetry at home (group 3) will wear the standard clinical sleep test system and the novel device. At the end of the trial, the acceptability of the novel device will be assessed.
Patients who are on mechanical ventilation and referred for diagnosis of sleep apnoea in hospital or at home will wear the standard clinical sleep test system and the novel device. At the end of the trial, the validity of the diagnosis from the novel device will be assessed.
Patients who are referred for either at home or in hospital diagnosis of sleep apnoea with a BMI SDS score of 3 or more will wear the standard clinical sleep test system and the novel device. At the end of the trial, we will compare the diagnosis results from both systems.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Renard Pramono, PhD
- Número de teléfono: +447721 877020
- Correo electrónico: renard@acurable.com
Ubicaciones de estudio
-
-
-
Sheffield, Reino Unido, S10 2TH
- Reclutamiento
- Sheffield Children Hospital
-
Contacto:
- Orsina Dessi
- Número de teléfono: +447721 877020
- Correo electrónico: orsina@acurable.com
-
Investigador principal:
- Heather Elphick
-
Southampton, Reino Unido
- Reclutamiento
- Southampton Children's Hospital
-
Contacto:
- Orsina Dessi
-
Investigador principal:
- Hazel Evans
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
all children who have been referred for a sleep test.
Descripción
Inclusion Criteria:
- Children older than one year old (older than eight years old for studies at-home) and below 18 years of age.
- Children who have been referred to a sleep clinic due to suspicion of sleep apnoea.
Exclusion Criteria:
- Patients whose parents/legal guardians/carers are not fluent in English, or who have special communication needs.
- Known allergy to the adhesive dressing.
- Patients with physical or mental impairments who would be too distressed with additional sensors on themselves.
- Patients with not enough space on the neck area to fit the sensor.
- Clinical problem in the area in which the device will be attached, eg skin condition ●. For patients conducting the study at home, patients with neurocognitive impairments which may increase the risk of them putting the sensor in their mouth, who do not have overnight carers
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
test group
Test group will wear PSG |
The patient will wear the novel wearable paediatric device at the same time as polysmnography |
|
Novel wearable device
THis group will wear the novel device |
The patient will wear the novel wearable paediatric device at the same time as polysmnography |
|
Home
40 consecutive patients (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who will have been referred for at home diagnosis of sleep apnoea or overnight oximetry at home. Each site will recruit, in parallel, consecutive patients from the moment the first patient in this group is recruited at that site. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 8 years old and referral for overnight assessment for evaluation of possible sleep apnoea. Additionally, patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. This patient cohort will be used to assess the acceptance of the AcuPebble technology in the home environment. |
The patient will wear the novel wearable paediatric device at the same time as polysmnography |
|
Ventilation
30 patients will be recruited (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who are on mechanical ventilation and have been referred for diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 1 year old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study in hospital, or over 8 years old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study at home. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of diagnostic validity. |
The patient will wear the novel wearable paediatric device at the same time as polysmnography |
|
High BMI
75 patients will be recruited (plus/minus 30% to account for potential dropouts, or invalid signals from the gold-standard), who have a BMI SDS score of 3 or more and have been referred for either at-home or in-hospital diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. If their study is to take place in the home, only children who are older than 8 will be included. If their study is to take place in hospital, children over the age of 1 will be included. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of sensitivity and specificity for this cohort. |
The patient will wear the novel wearable paediatric device at the same time as polysmnography |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Specificity and sensitivity of novel device
Periodo de tiempo: 6 months
|
specificity and sensitivity of the output of the novel wearable device against polysomnography |
6 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Director de estudio: Ruth Kingshott, PhD, Sheffield Children's NHS Foundation Trust
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 269747
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .